The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...
Nimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates ...
US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...
IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...
An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...
Obudanersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Angelman Syndrome.
Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.
The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report ...
Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...
For the first two to three weeks of their lives, infants have to undergo screening for neonatal jaundice (NNJ). It typically ...
News Medical on MSN2d
$21 million NIH grant will support next phase of high-impact, multidisciplinary Hispanic studyA multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community received a $21 million grant from the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback